uBiome CEO Jessica Richman Joins Sean Parker, Maria Shriver, Arianna Huffington and Others, Speaking at Fortune Brainstorm HEALTH

Share Article

Jessica Richman, co-founder and CEO of microbial genomics leader uBiome, will speak at the Fortune Brainstorm HEALTH event in San Diego this week. The gathering aims to unite a powerful new community of leaders at the forefront of the new healthcare revolution.

We envision a world in which our technology informs the day-to-day work of doctors, a world where screening a patient’s microbiome is as commonplace as a physician ordering a blood test is today.

Jessica Richman, PhD, co-founder, and Chief Executive Officer of uBiome, the world’s leading microbial genomics company, will join other speakers – including Deepak Chopra, Arianna Huffington, Sean Parker, and Maria Shriver – at the inaugural Fortune Brainstorm HEALTH event in San Diego on November 1 and 2.

Fortune Brainstorm HEALTH is an invitation-only conference that focuses on applying the problem-solving potential of new technologies in the world of healthcare in ways that can disrupt and transform the medical field. The theme of this inaugural event is “Seizing the Disruptive Opportunity.”

uBiome is the leading microbial genomics company, using DNA sequencing to identify the microorganisms in individuals’ microbiome, the diverse collection of microorganisms that live in and on the human body. Microorganisms in the gut play a supporting role in digestion and the synthesis of vitamins, but pathogenic microbes are associated with a range of conditions such as autoimmune disorders, diabetes, heart conditions, Inflammatory Bowel Disease, and skin conditions.

Dr. Richman says: “The gut microbiome is increasingly being associated with a wide range of conditions, but it’s probably never been more true that we can only manage what we can measure. At uBiome, we envision a world in which our technology informs the day-to-day work of doctors, a world where screening a patient’s microbiome is as commonplace as a physician ordering a blood test is today.”

Since uBiome’s launch four years ago, tens of thousands of citizen scientists have had their microbiome sequenced. At the event, uBiome will launch the first sequencing-based clinical microbiome test, SmartGutTM, which delivers specific information to doctors and patients about microorganisms critical to gut health.

Jessica will speak on Wednesday, November 2 at 11:00am.

Dr. Richman co-founded uBiome in 2012. Prior to founding uBiome, Dr. Richman worked for Google, McKinsey, Lehman Brothers, the Grameen Bank, and top-tier Silicon Valley venture firms. She attended Stanford University, studying economics and interdisciplinary engineering. After receiving a fellowship to Oxford University, she became a Fulbright Scholar and earned her PhD in computational social science.

uBiome’s mission is to explore important research questions about the microbiome and develop accurate and reliable clinical tests based on the microbiome. The company is funded by Andreessen Horowitz, Y Combinator, and other leading investors.

Contact:
Julie Taylor
julie(at)ubiome(dot)com
Ph: +1 (415) 212-9214

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Julie Taylor
uBiome
+1 (415) 275-2461
Email >
@uBiome
Follow >
Follow us on
Visit website